Fighting the risk of developing Parkinson's disease; clinical counseling for first degree relatives of patients with Parkinson's disease

被引:12
|
作者
Giladi, Nir [3 ]
Mirelman, Anat [1 ,4 ]
Thaler, Avner
Bar-Shira, Anat [2 ]
Gurevich, Tanya [3 ]
Orr-Urtreger, Avi [2 ,3 ]
机构
[1] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Neurol, Movement Disorders Unit, IL-64239 Tel Aviv, Israel
[2] Tel Aviv Univ, Tel Aviv Med Ctr, Genet Inst, IL-64239 Tel Aviv, Israel
[3] Tel Aviv Univ, Sackler Sch Med, IL-64239 Tel Aviv, Israel
[4] Ben Gurion Univ Negev, Beer Sheva, Israel
关键词
Parkinson's disease; LRRK2; gene; Clinical counseling; SMELL IDENTIFICATION TEST; OLFACTORY FUNCTION; ASHKENAZI JEWS; LRRK2; G2019S; EARLY-ONSET; MUTATIONS; NEUROPROTECTION; UNIVERSITY; MECHANISM; EXPOSURE;
D O I
10.1016/j.jns.2011.06.005
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Parkinson's disease (PD) has a long pre-diagnosis phase that may span as long as 10-20 years. The ability to identify at risk populations raises the possibility of early intervention to delay or prevent the onset of motor symptoms. In Israel, there is a large group of Ashkenazi Jews at risk of developing PD due to high frequency of PD associated mutations in 2 genes (GBA and LRRK2). Objective: To describe our unique experience with a clinical counseling service for 1st degree relatives of PD patients from the Ashkenazi origin who carry the G2019S mutation in the LRRK2 gene. Method: One hundred, self declared, healthy, first degree relatives of PD patients who carry the G2019S mutation in the LRRK2 gene were tested clinically and genetically in a cross sectional study. Those who have requested information on their risk to develop PD were invited to a free of charge, clinical counseling session to provide information on their risk of developing PD and potential risk modifiers that can be applied. Genetic status was not disclosed and the counselor was unaware of the subjects' G2019S mutation status. Results: 46 subjects (mean age 48.2 +/- 10.7; 46% males) came for clinical counseling provided by a Movement Disorders specialist Siblings and off-springs of the same proband were seen together. Counseling provided general information about the pre-diagnosis phase of PD, the concept of population at risk and habitual and behavioral recommendations that may delay PD motor symptoms onset. Conclusion: A high percentage of individuals at risk for developing PD requested clinical counseling on modifiers of the risk to develop PD. Counseling provided information as well as recommendations for behavioral modifications and drug treatment. Screening population at risk increases the awareness as well as early diagnosis of PD. Prospective information is needed in order to improve our knowledge base and assess the long term impact of such a counseling service. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:17 / 20
页数:4
相关论文
共 50 条
  • [41] Fighting Parkinson's ... and Winning: A memoir of my recovery from Parkinson's Disease
    Roman, Marian W.
    ISSUES IN MENTAL HEALTH NURSING, 2018, 39 (11) : 985 - 985
  • [42] Developing therapies for Parkinson's disease
    不详
    LANCET NEUROLOGY, 2020, 19 (10): : 797 - 797
  • [43] Parkinson's disease in the developing world
    Carr, JA
    MOVEMENT DISORDERS, 2006, 21 : S49 - S49
  • [44] Knowledge about Parkinson's disease in patients with Parkinson's disease: A survey
    Jandeaw, Onnalin
    Bhidayasiri, Roongroj
    Jagota, Priya
    Singmaneesakulchai, Surat
    Jitkritsadakul, Onanong
    Boonrod, Nonglak
    Kaewwilai, Lalita
    Boonpang, Kamolwan
    Devahastin, Ratanaruedee
    Brenden, Neil
    MOVEMENT DISORDERS, 2014, 29 : S17 - S18
  • [45] Clinical phenotype in patients with α-synuclein Parkinson's disease living in Greece in comparison with patients with sporadic Parkinson's disease
    Papapetropoulos, S
    Paschalis, C
    Athanassiadou, A
    Papadimitriou, A
    Ellul, J
    Polymeropoulos, MH
    Papapetropoulos, T
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2001, 70 (05): : 662 - 665
  • [46] [I-123]beta-CIT SPECT imaging in first degree relatives of Parkinson's disease patients.
    OConnor, MK
    Maraganore, DM
    Mullan, BP
    Bower, JH
    Kuntz, K
    Hung, JCY
    Rocca, WA
    Monvillle, M
    Hauser, MF
    JOURNAL OF NUCLEAR MEDICINE, 1997, 38 (05) : 519 - 519
  • [47] Lower caffeine consumption is associated with reduced olfactory function in first degree relatives of patients with Parkinson's disease: A pilot study
    Connolly, J
    Siderowf, A
    Stern, M
    NEUROLOGY, 2006, 66 (05) : A214 - A214
  • [48] Season of birth and risk of developing idiopathic Parkinson's disease
    McGhee, David
    Counsell, Carl
    PARKINSONISM & RELATED DISORDERS, 2012, 18 (05) : 675 - 676
  • [49] Stalin use and the risk of developing Parkinson's disease in Denmark
    Ritz, B.
    Wahner, A. D.
    Qian, L.
    Schernhammer, E.
    Olsen, J.
    Friis, S.
    MOVEMENT DISORDERS, 2009, 24 : S129 - S130
  • [50] The vermiform appendix impacts the risk of developing Parkinson's disease
    Killinger, Bryan A.
    Madaj, Zachary
    Sikora, Jacek W.
    Rey, Nolwen
    Haas, Alec J.
    Vepa, Yamini
    Lindqvist, Daniel
    Chen, Honglei
    Thomas, Paul M.
    Brundin, Patrik
    Brundin, Lena
    Labrie, Viviane
    SCIENCE TRANSLATIONAL MEDICINE, 2018, 10 (465)